A novel DHP L-type Ca2+ channel blocker that also inhibits Syk.1 Blocks Abeta production, APPbeta secretion and reduces BACE-1 expression in CHO cells over-expressing Abeta in vitro. Enhances clearance of Abeta across the blood brain barrier in vivo. Reduces brain A
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten